DUBLIN, September 9, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Europe Type 2 Diabetes Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
Europe Type 2 Diabetes Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Type 2 Diabetes pipeline products, Type 2 Diabetes epidemiology, Type 2 Diabetes market valuations and forecast, Type 2 Diabetes products sales and competitive landscape.
This report is classified into nine sections - Type 2 Diabetes overview including etiology, pathophysiology, and diagnosis, Type 2 Diabetes treatment options, Type 2 Diabetes pipeline products, Type 2 Diabetes market analysis in Europe and by each country.
The market analysis comprises of Type 2 Diabetes epidemiology, key products marketed for Type 2 Diabetes, market valuations and forecast, products sales and market shares.
- Pipeline: Find out the products in clinical trials for the treatment of Type 2 Diabetes by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Epidemiology: Find out the number of patients diagnosed (prevalence) with Type 2 Diabetes
- Products: Identify key products marketed and prescribed for Type 2 Diabetes including trade name, molecule name, and company
- Product Sales: Find out the sales revenues of Type 2 Diabetes products, both branded and generics
- Market Valuations: Find out the market size for Type 2 Diabetes products in 2015 for the markets: Find out how the market advanced from 2010 and forecast to 2020
- Products Market Share: Find out the market shares for key Type 2 Diabetes products
Key Topics Covered:
1 Disease Overview
2 Type 2 Diabetes Treatments
3 Type 2 Diabetes Pipeline
4 Europe Type 2 Diabetes Market Insights
5 Germany Type 2 Diabetes Market Insights
6 France Type 2 Diabetes Market Insights
7 Italy Type 2 Diabetes Market Insights
8 Spain Type 2 Diabetes Market Insights
9 UK Type 2 Diabetes Market Insights
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/dg4p39/europe_type_2
Related Topics: Endocrine and Metabolic Disorder Drugs
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets